
Opinion|Videos|October 24, 2024
Clinical Presentation and Risk Factors
Author(s)Toby Maher, MD, PhD
Key Takeaways
- IPF diagnosis relies on clinical evaluation, HRCT, and occasionally lung biopsy to identify usual interstitial pneumonia patterns.
- The average time to IPF diagnosis can be delayed up to two years due to symptom overlap with other conditions.
Toby Maher, MD, PhD, discusses how common signs and symptoms of idiopathic pulmonary fibrosis (IPF) at diagnosis can indicate disease progression, while also identifying key risk factors associated with IPF and emphasizing the importance of modifying certain lifestyle factors to help prevent the disease.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What signs and symptoms of IPF are often present at diagnosis, and what patient characteristics at the time of diagnosis may be predictive of disease progression?
- What risk factors are associated with IPF, and what changes can be made to modifiable risk factors to prevent the disease?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
3
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5